Bayer shares slumped after the company was ordered to pay $2.25 billion in damages, the latest setback in its legal battle over its Roundup weedkiller's alleged cancer risk.

Bayer shares slumped after the company was ordered to pay $2.25 billion in damages, the latest setback in its legal battle over its Roundup weedkiller’s alleged cancer risk.